Logo image of ATON

ALPHATON CAPITAL CORP (ATON) Stock Overview

USA - NASDAQ:ATON - VGG7185A1369 - Common Stock

6.25 USD
+0.23 (+3.82%)
Last: 9/25/2025, 8:20:19 PM
5.79 USD
-0.46 (-7.36%)
After Hours: 9/25/2025, 8:20:19 PM

ATON Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap14.25M
Shares2.28M
Float900.00K
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.72
PEN/A
Fwd PEN/A
Earnings (Next)11-24 2025-11-24
IPO10-28 2013-10-28
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ATON short term performance overview.The bars show the price performance of ATON in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

ATON long term performance overview.The bars show the price performance of ATON in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ATON is 6.25 USD.

ALPHATON CAPITAL CORP / ATON Daily stock chart

ATON Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.64 386.06B
AMGN AMGEN INC 12.43 145.99B
GILD GILEAD SCIENCES INC 14.34 137.72B
VRTX VERTEX PHARMACEUTICALS INC 22.54 97.91B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.93B
REGN REGENERON PHARMACEUTICALS 12.17 58.88B
ARGX ARGENX SE - ADR 76.71 43.52B
ONC BEONE MEDICINES LTD-ADR 5.75 39.08B
INSM INSMED INC N/A 28.66B
BNTX BIONTECH SE-ADR N/A 23.58B
NTRA NATERA INC N/A 22.46B
BIIB BIOGEN INC 8.47 19.89B

About ATON

Company Profile

ATON logo image Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is engaged in advancing therapies to improve long-term treatment, response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. Its adenosine antagonist platform include PORT-9 and PORT-8. PORT-9 and PORT-8 are in the preclinical stage. Its PORT-8 is a dual inhibitor of adenosine receptors 2A and 2B (A2A/A2B) to address solid tumors. Its PORT-9 is an A2B antagonist designed to treat colorectal and gastrointestinal cancers. Its iNKT Engager platform includes PORT- 3, which is in Phase I.

Company Info

ALPHATON CAPITAL CORP

Clarence Thomas Building, P.O. Box 4649, Road Town

Tortola ONTARIO VG

Employees: 3

ATON Company Website

ATON Investor Relations

Phone: 4167377600

ALPHATON CAPITAL CORP / ATON FAQ

What is the stock price of ALPHATON CAPITAL CORP today?

The current stock price of ATON is 6.25 USD. The price increased by 3.82% in the last trading session.


What is the ticker symbol for ALPHATON CAPITAL CORP stock?

The exchange symbol of ALPHATON CAPITAL CORP is ATON and it is listed on the Nasdaq exchange.


On which exchange is ATON stock listed?

ATON stock is listed on the Nasdaq exchange.


What is ALPHATON CAPITAL CORP worth?

ALPHATON CAPITAL CORP (ATON) has a market capitalization of 14.25M USD. This makes ATON a Nano Cap stock.


How many employees does ALPHATON CAPITAL CORP have?

ALPHATON CAPITAL CORP (ATON) currently has 3 employees.


What are the support and resistance levels for ALPHATON CAPITAL CORP (ATON) stock?

ALPHATON CAPITAL CORP (ATON) has a support level at 6.01. Check the full technical report for a detailed analysis of ATON support and resistance levels.


Should I buy ALPHATON CAPITAL CORP (ATON) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ALPHATON CAPITAL CORP (ATON) stock pay dividends?

ATON does not pay a dividend.


When does ALPHATON CAPITAL CORP (ATON) report earnings?

ALPHATON CAPITAL CORP (ATON) will report earnings on 2025-11-24.


What is the Price/Earnings (PE) ratio of ALPHATON CAPITAL CORP (ATON)?

ALPHATON CAPITAL CORP (ATON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.72).


ATON Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ATON.


Chartmill TA Rating
Chartmill Setup Rating

ATON Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ATON. ATON may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATON Financial Highlights

Over the last trailing twelve months ATON reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 92.66% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -304.13%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%75.91%
Sales Q2Q%N/A
EPS 1Y (TTM)92.66%
Revenue 1Y (TTM)N/A

ATON Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y0%
Revenue Next YearN/A

ATON Ownership

Ownership
Inst Owners2.21%
Ins Owners35.54%
Short Float %N/A
Short RatioN/A